• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

Techcouver.com

 
 
 
  • News
  • Web3
  • Thought Leadership
  • Bulletin Board
  • Job Board
  • About
    • Contact Us
  • Advertise
You are here: Home / News / Notch Therapeutics Raises USD $85 Million For Stem Cell-Derived Cancer Immunotherapies

Notch Therapeutics Raises USD $85 Million For Stem Cell-Derived Cancer Immunotherapies

February 11, 2021 by Techcouver Newsdesk Leave a Comment

Vancouver’s Notch Therapeutics  has closed a USD $85 million Series A financing led by an exclusively healthcare-focused investment fund, with participation by existing investors including Vancouver’s Lumira Ventures.

Notch is developing renewable, stem cell-derived immunotherapies, with an initial focus on cancer.

Proceeds from the financing will support the continuing development of Notch’s portfolio of iPSC-derived T cell therapeutic product candidates and clinical readiness of the company’s proprietary Engineered Thymic Niche (ETN) platform.

The financing will also enable Notch to expand its team to support the company’s future growth, including establishing operations in Seattle, in addition to the company’s existing operations in Vancouver and Toronto.

“We are gratified to have the confidence of this exceptional group of investors and have them share in our vision that our platform can be game-changing for cell therapies by easing cell manufacturing and broadening their clinical and commercial potential,” said David Main, President and Chief Executive Officer of Notch.

“The level of interest in this financing round enabled us to far exceed our original capital-raising goals. With this support, Notch is well positioned to support our partners and advance development of our initial cell therapy products for patients with cancer.”

Filed Under: News Tagged With: Notch Therapeutics

 
 
 

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Primary Sidebar

 
 
 

Stay Connected

About Us

Techcouver provides real-time reporting and analysis of emerging technology news in Vancouver and throughout British Columbia. The … READ MORE... about About Us

Copyright © 2022 Incubate Ventures

Privacy Policy